John Sim

[John Sim @JJSim008]

Real-World Eligibility for FSGS Clinical Trials: Insights from a US Health System https://t.co/MFe0KGQrQC

[John Sim @JJSim008]

https://t.co/xQfh69NF3x

[John Sim @JJSim008]

Rethinking Primary Aldosteronism: The 2025 John H. Laragh Research Award https://t.co/9f4jKnGqjZ

[John Sim @JJSim008]

CKD progression, kidney failure, and mortality among US patients with IgA nephropathy https://t.co/O1i4aZUcET

[John Sim @JJSim008]

https://t.co/koge16j6I5

[John Sim @JJSim008]

https://t.co/YRQZuLgUuS$

[John Sim @JJSim008]

https://t.co/PJHBOILfDO

[John Sim @JJSim008]

Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and Ch… https://t.co/6IaxiFs0T6

[John Sim @JJSim008]

Identifying alcoholic liver disease patients using electronic health records within an integrated health system. https://t.co/cfeZLv7Yo0

[John Sim @JJSim008]

https://t.co/8FilFOmecc

[John Sim @JJSim008]

https://t.co/Xl3hIRIknJ

[John Sim @JJSim008]

Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors - An - The Journal of Clinical Hypertension - Wiley Online Library https://t.co/bjOrMEqtG3

[John Sim @JJSim008]

Beta blockers not all the same for patients with heart failure and CKD https://t.co/qQSB5qieud

[John Sim @JJSim008]

Comparative Effectiveness of Bisoprolol, Carvedilol, and... : Clinical Journal of the American Society of Nephrology https://t.co/ned52x3sBc

[John Sim @JJSim008]

Minimal Change Disease (MCD) and Focal Segmental... : Kidney360 https://t.co/7nbFuFyZim

[John Sim @JJSim008]

Data driven approach to characterize rapid decline in autosomal dominant polycystic kidney disease https://t.co/fD5hbXcSLF

[Coin Hunter @bycoinhunter]

🎁BİNLERCE DOLARLIK ETKİNLİK

10 kişiye Bluezilla'nın yeni projesi #BlastFi'den WL veriyorum!🔥Üstelik %100 TGE - Kilit yok!

1⃣ Takip: @Blast_Fi
2⃣ Katıl: https://t.co/7YHAqP2efH
3⃣ RT - FAV

⤵️Ekstra WL için herkese açık form
https://t.co/nT0Osw72mK

[John Sim @JJSim008]

https://t.co/SMTxqLLGrZ